Diagnostic application of flow cytometric characteristics of CD34+ cells in low-grade myelodysplastic syndromes
- 1 August 2006
- journal article
- Published by American Society of Hematology in Blood
- Vol. 108 (3) , 1037-1044
- https://doi.org/10.1182/blood-2005-12-4916
Abstract
The diagnosis of myelodysplastic syndromes (MDS) without an increase in blasts and ringed sideroblasts (low-grade MDS without ringed sideroblasts [LGw/oRS]) may be problematic because dysplastic features are not specific to MDS and approximately 50% of patients with LGw/oRS lack chromosomal aberrations. Here, we report the usefulness of flow cytometric characteristics of CD34+ cells for LGw/oRS diagnosis. Bone marrow cells from LGw/oRS patients and controls (eg, cytopenic individuals without MDS) were analyzed using 4-color flow cytometry (FCM). We objectively determined reference ranges of 13 parameters related to CD34+ cells with data from controls. In LGw/oRS patients, various abnormalities of CD34+ cells—eg, decrease in CD34+ B-cell precursors, aberrant expression or overexpression of various antigens on CD34+ myeloblasts—were observed. We constructed a reproducible, flow cytometric scoring system for LGw/oRS diagnosis. High scores were observed in 16 of 27 LGw/oRS patients, regardless of the presence or absence of chromosomal aberrations, but not in any of the 90 controls. Among LGw/oRS patients with chromosomal aberrations, patients with trisomy 8 or del20(q) had low FCM scores (P = .002). As a result, most LGw/oRS patients were identified based on high FCM score, chromosomal aberration, or both.Keywords
This publication has 33 references indexed in Scilit:
- Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndromeBlood, 2005
- Prognostic Factors and Life Expectancy in Myelodysplastic Syndromes Classified According to WHO Criteria: A Basis for Clinical Decision MakingJournal of Clinical Oncology, 2005
- Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromesBlood, 2005
- A Comparative Review of Classification Systems in Myelodysplastic Syndromes (MDS)Seminars in Oncology, 2005
- Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndromeBlood, 2005
- Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantationBlood, 2003
- The World Health Organization (WHO) classification of the myeloid neoplasmsBlood, 2002
- Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndromeBlood, 2002
- Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromesBritish Journal of Haematology, 2000
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982